CircuLex CEL-BSA /Nε-(Carboxyethyl)lysine-BSA
Code | Size | Price |
---|
MBL-CY-R2054 | 200 ug | £285.00 |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Application: Enzyme-Linked Immunosorbent Assay (ELISA)
Shipping:
dry ice
Storage:
-20°C
Documents
Further Information
Applications:
ELISA - 200-800 ng/ml
Background:
Reducing sugars react with protein amino groups to form a
diverse group of protein-bound moieties with fluorescent and
cross-linking properties. These compounds, called advanced
glycosylation end products (AGEs), have been implicated in the
structural and functional alterations of proteins that occur during
aging and long-term diabetes. Although several AGE structures
have been reported (1, 2), Nε-(Carboxymethyl) lysine (CML) and
Nε-(carboxyethyl)lysine (CEL) stable, nonenzymatic chemical
modifications of protein lysine residues resulting from glycation
and oxidation reactions. CEL is a homologue of CML that is
formed by the reaction of lysine residues in proteins with
methylglyoxal as well as with triose phosphates and other sugars
(3). CML and CEL are two major nonenzymatic chemical
modifications on tissue proteins that can serve as biomarkers of
oxidative stress resulting from sugar and lipid oxidation. CEL was
detected in human skin collagen at 5?10% of the concentration
detected in lens proteins from donors of similar age, and its
concentration was approx. 8-fold higher in a pool of skin collagen
samples from old, compared with young, donors (3). These
observations suggest that CEL, like CML, will be a useful
biomarker of the chemical aging of tissue proteins (4, 5).
Concentration:
1.0 mg/mL
Formulation:
The CE L-BSA /Nε-(carboxyethyl) lysine-BSA is supplied frozen in
a buffer containing 10 mM PBS (pH 7.2).
Gene IDs:
Human: 1056 Mouse: 12613
Shelf Life:
1 year
References
(1) Ikeda K, Higashi T, Sano H, Jinnouchi Y, Yoshida M, Araki T,
Ueda S, Horiuchi S: Biochemistry 35: 8075 ?8083,1996 (2) Reddy S, Bichler J, Wells-Knecht KJ, Thorpe SR, Baynes JW:
Biochemistry 34: 10872?10878, 1995
(3) MU Ahmed, E Brinkmann Frye, TP Degenhardt, SR Thorpe,
and JW Baynes: Biochem J, 324:565-70, 1997
(4) Teerlink T, Barto R, Ten Brink HJ, Schalkwijk CG. Clin. Chem.
50:1222-8, 2004
(5) Lieuw-A-Fa ML, van Hinsbergh VW, Teerlink T, Barto R, Twisk
J, Stehouwer CD, Schalkwijk CG. Nephrol. Dial Transplant.
19:631-6, 2004